Terms: = Breast cancer AND FEV, Pet-1, 54738, ENSG00000163497, PET-1, HSRNAFEV AND Treatment
10 results:
1. Pulmonary Function and Lung Fibrosis up to 12 Years After breast cancer Radiotherapy.
Karlsen J; Tandstad T; Steinshamn S; Salvesen Ø; Parlikar ND; Lundgren S; Reidunsdatter RJ
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(4):1066-1077. PubMed ID: 38099884
[TBL] [Abstract] [Full Text] [Related]
2. Long-term results of sirolimus treatment in lymphangioleiomyomatosis: a single referral centre experience.
Revilla-López E; Berastegui C; Méndez A; Sáez-Giménez B; Ruiz de Miguel V; López-Meseguer M; Monforte V; Bravo C; Pujana MA; Ramon MA; Gómez-Ollés S; Roman A;
Sci Rep; 2021 May; 11(1):10171. PubMed ID: 33986388
[TBL] [Abstract] [Full Text] [Related]
3. Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer.
Groheux D; Biard L; Lehmann-Che J; Teixeira L; Bouhidel FA; Poirot B; Bertheau P; Merlet P; Espié M; Resche-Rigon M; Sotiriou C; de Cremoux P
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1279-1288. PubMed ID: 29616304
[TBL] [Abstract] [Full Text] [Related]
4. [Can Pulmonary Rehabilitation during Preoperative Chemoradiotherapy for Non-small Cell Lung cancer Improve the Respiratory Function?].
Tokunaga Y; Tarumi S; Yokomise H
Kyobu Geka; 2016 Jan; 69(1):47-52. PubMed ID: 26975643
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic Role of Early and End-of-Neoadjuvant treatment 18F-FDG PET/CT in Patients With breast cancer.
García Vicente AM; Amo-Salas M; Relea Calatayud F; Muñoz Sánchez Mdel M; Pena Pardo FJ; Jiménez Londoño GA; Álvarez Cabellos R; Espinosa Aunión R; Soriano Castrejón Á
Clin Nucl Med; 2016 Jul; 41(7):e313-22. PubMed ID: 26953659
[TBL] [Abstract] [Full Text] [Related]
6. Molecular subtypes of breast cancer: metabolic correlation with ¹⁸F-FDG PET/CT.
García Vicente AM; Soriano Castrejón Á; León Martín A; Chacón López-Muñiz I; Muñoz Madero V; Muñoz Sánchez Mdel M; Palomar Muñoz A; Espinosa Aunión R; González Ageitos A
Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1304-11. PubMed ID: 23632960
[TBL] [Abstract] [Full Text] [Related]
7. Changes in pulmonary function up to 10 years after locoregional breast irradiation.
Erven K; Weltens C; Nackaerts K; Fieuws S; Decramer M; Lievens Y
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):701-7. PubMed ID: 21398052
[TBL] [Abstract] [Full Text] [Related]
8. tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation.
Wardley AM; Hiller L; Howard HC; Dunn JA; Bowman A; Coleman RE; Fernando IN; Ritchie DM; Earl HM; Poole CJ;
Br J Cancer; 2008 Aug; 99(4):597-603. PubMed ID: 18665163
[TBL] [Abstract] [Full Text] [Related]
9. Effects of supervised exercise training on cardiopulmonary function and fatigue in breast cancer survivors during and after treatment.
Schneider CM; Hsieh CC; Sprod LK; Carter SD; Hayward R
Cancer; 2007 Aug; 110(4):918-25. PubMed ID: 17582616
[TBL] [Abstract] [Full Text] [Related]
10. Serial HRCT lung changes after 3-field radiation treatment of breast cancer.
Ooi GC; Kwong DL; Chan KN; Ngan H; Lock DT; Lam WK; Chan FL; Au G; Tsang KW
Clin Radiol; 2000 Nov; 55(11):817-24. PubMed ID: 11069735
[TBL] [Abstract] [Full Text] [Related]
